Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Threshold Pharmaceuticals Company Profile (NASDAQ:THLD)

Consensus Ratings for Threshold Pharmaceuticals (NASDAQ:THLD) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00 (257.14% upside)

Analysts' Ratings History for Threshold Pharmaceuticals (NASDAQ:THLD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/8/2014Brean CapitalInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014ZacksUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
2/20/2013Piper JaffrayUpgradeNeutral -> Overweight$5.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
1/17/2013Piper JaffrayInitiated CoverageNeutral$5.00ViewTweet This Rating  Share This Rating on StockTwits
11/21/2012Brean CapitalInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2012Maxim GroupReiterated RatingBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2012Stifel NicolausBoost Price TargetBuy$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
9/20/2012Maxim GroupInitiated CoverageBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
8/24/2012Stifel NicolausInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)